Paper3948299
The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.
Harpur ES and 3 others. Cancer Chemother Pharmacol, 1986. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination. Papers, record 3948299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3948299
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Formamides | Major topic |
| Kidney | Major topic |
| Liver | Major topic |
| Animals | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Blood Cell Count | |
| Blood Urea Nitrogen | |
| Calcium | |
| Creatinine | |
| Drug Evaluation, Preclinical | |
| Female | |
| Injections, Intraperitoneal | |
| L-Lactate Dehydrogenase | |
| Lethal Dose 50 | |
| Leukocyte Count | |
| Leukopenia | |
| Male | |
| Mice | |
| Rats | |
| Rats, Inbred F344 | |
| Sarcoma, Experimental |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 276884 | Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/276884 | PubMed |
| 3 | 1021237 | Comparative nephrotoxicity of platinum cancer chemotherapeutic agents. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/1021237 | PubMed |
| 4 | 240515 | Reaction-rate assay of serum sorbitol dehydrogenase activity of 37 degrees C. | Clin Chem | 1975 | https://conductscience.org/library/papers/240515 | PubMed |
| 5 | 4018116 | N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapy. | Eur J Cancer Clin Oncol | 1985 | https://conductscience.org/library/papers/4018116 | PubMed |
| 6 | 6931873 | Acute renal tubular dysfunction following cis-dichlorodiammine platinum therapy. | J Med | 1980 | https://conductscience.org/library/papers/6931873 | PubMed |
| 7 | 6127169 | Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6127169 | PubMed |
| 8 | 5350464 | Enzymes in rat urine. I. A metabolism cage for the complete separation of urine and faeces. | Enzymologia | 1969 | https://conductscience.org/library/papers/5350464 | PubMed |
| 10 | 7139607 | Inhibition of the growth of human colon cancer xenografts by polar solvents. | Cancer Res | 1982 | https://conductscience.org/library/papers/7139607 | PubMed |
| 11 | 7027859 | Renal and electrolyte disturbances associated with cisplatin. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/7027859 | PubMed |
| 12 | 638991 | Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. | Cancer | 1978 | https://conductscience.org/library/papers/638991 | PubMed |
| 13 | 4336672 | [Isolation and characterization of a plasma membrane fraction from the proximal tubules of human kidney]. | Clin Chim Acta | 1972 | https://conductscience.org/library/papers/4336672 | PubMed |
| 14 | 6987030 | Comparison of methods of evaluating nephrotoxicity of cis-platinum. | Clin Pharmacol Ther | 1980 | https://conductscience.org/library/papers/6987030 | PubMed |
| 15 | 6704151 | An investigation of the mechanism of hepatotoxicity of the antitumour agent N-methylformamide in mice. | Biochem Pharmacol | 1984 | https://conductscience.org/library/papers/6704151 | PubMed |
| 16 | 375794 | Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. | Ann Intern Med | 1979 | https://conductscience.org/library/papers/375794 | PubMed |
| 19 | 6428895 | The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcoma. | Eur J Cancer Clin Oncol | 1984 | https://conductscience.org/library/papers/6428895 | PubMed |
| 20 | 6325001 | Phase I trial of N-methylformamide. | Cancer Treat Rep | 1984 | https://conductscience.org/library/papers/6325001 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8913832 | Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis. | Invest New Drugs | 1996 | https://conductscience.org/library/papers/8913832 | PubMed |
| 3665221 | Antitumor and antimetastatic activity of the differentiating agent N-methylformamide in murine tumor systems. | Clin Exp Metastasis | 1987 | https://conductscience.org/library/papers/3665221 | PubMed |
| 2599802 | Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study. | Invest New Drugs | 1989 | https://conductscience.org/library/papers/2599802 | PubMed |
| 2328201 | Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2328201 | PubMed |
| 2066356 | Different effects of sequential combinations of N-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice. | J Cancer Res Clin Oncol | 1991 | https://conductscience.org/library/papers/2066356 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3948299
GET https://conductscience.org/api/papers/v1/3948299/authors